简介内容：RET-IN-4 is a highly effective and specific RET inhibitor that can be administered orally. It demonstrates remarkable potency, with IC50 values of nM, nM, and nM for inhibiting RET variants including RET (WT), RET (V804M), and RET (M918T), respectively. Moreover, RET-IN-4 exhibits superior selectivity towards kinases JAK2 (IC50 of nM) and FLT3 (IC50 of nM). Additionally, RET-IN-4 possesses pronounced anticancer properties.
Customer Service
